| Literature DB >> 35836587 |
Michelle L Kearns1,2, Fionn MacAindriu1, Clare M Reynolds1,2.
Abstract
Understanding the factors which influence fertility is essential for developing appropriate nutritional recommendations for couples trying to conceive. Non-caloric sweeteners (NCS) are increasing in the food chain and despite being no/low calorie, several adverse metabolic consequences have been attributed to their consumption. Their effects on reproduction have been relatively under-researched, particularly in males. This review aims to systematically review the literature for evidence of the effect of NCS on male fertility in rodents, with sperm parameters (sperm quantity and quality) assessed as primary outcomes. Given the lack of information available in humans this review has been carried out using evidence from rodent models. Risk of bias assessment was carried out using the Syrcle risk of bias tool. Nine studies met the inclusion criteria. Forty-four percent showed a negative effect of NCS on male reproductive parameters compared with controls. The effects of NCS on fertility have been conflicting and selected studies have been heterogeneous in relation to study design. It is unclear if NCS has an impact on male reproductive function. There is a need for randomized controlled trials using a standardized protocol for analysis, to formulate a clear message in terms of male fertility.Entities:
Keywords: artificial sweetener; male fertility; rodent model; sperm quality; systematic review
Year: 2022 PMID: 35836587 PMCID: PMC9274198 DOI: 10.3389/fnut.2022.854074
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Eligibility criteria.
|
|
| •Intervention studies |
|
|
| •Non-intervention studies |
Inclusion and exclusion criteria prioritized for title and abstract, and full text screening.
Main characteristics and findings of the included studies.
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| Anbara et al. ( | Aspartame | 0.5 ml saline | 4 groups: C, LD, MD, HD: 40, 80 and 160 mg/kg. Oral Gavage | NMRI Mice | 36 | 90 days | Reduced sperm count in dose-dependent manner*, reduced sperm motility in MD and HD groups*, increased abnormal sperm morphology and DNA sperm damage in MD and HD groups*, effect in sperm viability in MD and HD groups, decreased sperm survival rate in MD and HD groups*, decreased Johnsen's score* | Increase in testicular capsule thickness in HD group*, decrease in seminiferous tubules diameter and germinal epithelium height in MD & HD groups* | Oral gavage administered study |
| Curry et al. ( | Rebaudioside A | Standard chow & water | 4 groups: 0, 1,506, 3,040, and 5,828 mg/kg/day weeks 0–12 and 0, 698, 1,473, and 3,147 mg/kg/day week 13. Diet | Wistar Rats | 80 | 13 weeks | No effects on either spermatogenesis/testicular atrophy were detected on microscopic evaluation | Decreased epididymal weights in HD group* | Very high dosage - not translatable to human intakes, dose changed on final week of study. No data was provided on spermatogenesis findingsa |
| Curry et al. ( | Rebaudioside A | Standard chow & water | 4 groups: 0, 586, 975, and 2,048 mg/kg/day. Diet | Wistar Rats | 128 | 10 weeks | No effect on cauda epididymis/testis sperm count in HD group vs. control, small decrease in sperm motility in group 2 (586 mg/kg/day), no effect on sperm morphology between HD & control group | No effect on weights, macroscopic and microscopic examinations of epididymis and testis | Very high dosage - not translatable to human intakes, sperm count, and morphology only Reported for control & HD. Females in same group as males - gestational data not included |
| Gong et al. ( | Saccharin | Standard chow & water or Sucrose | 4 groups: Feed (%): C: 0, HD: 0.080, MD: 0.020, LD: 0.005. Water (mM): HD: 7.0, MD: 3.5, LD: 0.7. Diet | ICR Mice | 84 | 35 days | Dose-response manner effect seen. In HD group: Reduced sperm count*, decreased | HD: damage from the periphery to lumen of seminiferous tubules vs. control, wide-area seminiferous epithelial cells exfoliated from the basal layer of tubules, clusters of discohesive spermatogenic cells visible | |
| Kille et al. ( | Sucralose | Distilled water | 4 groups: Control, 6-chloroglucose 24 mg/kg/day, Sucralose 500mg/kg/day, TCDS, 100 mg/kg/day, oral gavage | Sprague-Dawley Rats | 40 | 28 days | No significant inter-group differences in mean sperm concentration between groups including NCS and C | N/A | Very high dosage - not translatable to human intakes. Oral gavage route administered. Sperm motility, morphology or viability not assessed |
| Machemer et al. ( | Saccharin | 0.5 ml of demineralized water/ 20g/ weight | 2 groups: Control, 5g/kg/day Oral solution in water | NMRI/BOM Mice | 20 | 5 days | No significant differences in fertilization rate, pre or post-implantation rate of NCS group vs. control | N/A | Short study duration, it was acknowledged that there are known difficulties involved in the evaluation of pre-implantative loss |
| Melis et al. ( | Rebaudioside A | saline | 2 groups: Control, 66.7g of dried leaves/100 ml final solution, Gastric Tubing | Wistar Rats | 20 | 60 days | Reduced sperm concentration in NCS group* | Reduced cauda epididymis, seminal vesicle + testis weight in NCS group* | Sperm motility, morphology or viability not assessed, gastric tubing administered route |
| Otabe et al. ( | Advantame | Standard chow and water | 2,000, 10,000, or 50,000 ppm/ 164, 833, and 4,410 mg/kg bw/day, diet | Crl:CD (SD) IGS BR Rats | 136 | 5 weeks | No significant effects in sperm count, motility or abnormal sperm morphology between HD and control | N/A | Large NCS dose - not translatable to humans. Fertility analysis was carried out on control and HD only |
| Rahimipour et al. ( | Saccharin | Standard chow and water | 2 groups: control, 0.2% w/v, water | BALB/CMice | 14 | 35 days | Reduced sperm count, sperm motility and sperm viability in NCS group*, Increased abnormal sperm morphology apoptosis and rates of sperm with DNA fragmentation in NCS group* | N/A | Small sample size |
C, control; HD, High dose; MD, Medium dose; LD, Low dose.
.
Figure 1The PRISMA flow diagram for the systematic review detailing the database searches, the number of abstarcts screened, and the full texts retrieved.
Data of included studies reporting sperm count outcomes in NCS studies.
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
| Anbara et al. ( | Aspartame | ×106/ml | Standard hemocytom-eter method | Table. mean ± SD | 34.7 ± 1.7* | 31.6 ± 1.4* | 27.4 ± 1.8* | 19.2 ± 1.5* |
| Curry et al. ( | Rebaudioside A | Millions/g for c.a and t | NR | Table. mean ± SD | 790 ± 182ce 217 ± 34t |
|
|
|
| NR | NR | 790 ± 171ce | ||||||
| Gong et al. ( | Saccharin | ×106/ml | Neubauer chamber | Bar chart. approx (~) mean | ~70* |
|
|
|
| ~70* | ~75* | ~55* | ||||||
| Kille et al. ( | Sucralose | ×108/ml | Standard hemocytom-eter method | Table. mean ± SD | 0.8 ± 0.2 | 0.8 ± 0.2 | ||
| Melis et al. ( | Rebaudioside A | no./ml ×10 | NR | Table. mean ± SEM | 173.7 ± 8.0 | 117.7 ± 9.0* | ||
| Otabe et al. ( | Advantame | Millions/g for c.a and t | Hamilton Thorne IVOS Computer Assisted Sperm Analyzer (CASA) v 12.0. | Table. mean ± SD | 587 ± 127ce 138 ± 32t |
|
|
|
| NR | NR | 553 ± 162ce | ||||||
| Rahimipour et al. ( | Saccharin | ×106/ml | Makler chamber | Table. mean ± SD | 17.7 ± 1.1 | 12.8 ± 2.8 | ||
C, control; LD, low dose; MD, middle dose; HD, high dose.
c.a, cauda epididymis; t, testis; NR, not recorded.
Figure 2Risk of bias.